Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate forms a stable cyclic peptide enriched with charged and polar residues. The ring constraint enhances resistance to conformational drift and aids binding-site modeling. Researchers study its interaction geometry and rigidity in solution. Use spans biomaterial design, adhesion-motif analysis, and structural optimization.
CAT No: R2649
CAS No:135432-37-0
Synonyms/Alias:135432-37-0;Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) Trifluoroacetate;DA-72465;Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro) trifluoroacetate salt;2-[(3S,6S,12S,18S)-12-[3-(diaminomethylideneamino)propyl]-3-(hydroxymethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-6-yl]acetic acid;2,2,2-trifluoroacetic acid;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.